Table 2.
BstUI and MspI polymorphisms of the p53 gene genotype frequencies in Turkish schizophrenia and lung cancer patients and control groups.
| Genotype distribution | ||||||||
|---|---|---|---|---|---|---|---|---|
| A1-A1 | A2-A2 | A1-A2 | ||||||
| BstUI | n | % | n | % | n | % | X 2 | P |
| Schizophrenia (n = 100) | 38 | 38.0 | 43 | 43.0 | 19 | 19.0 | 9.620 | <.01 |
| Lung cancer (n = 100) | 5 | 5.0 | 87 | 87.0 | 8 | 8.0 | 129.740 | <.001 |
| Controls (n = 100) | 22 | 22.0 | 33 | 33.0 | 45 | 45.0 | 7.940 | <.05 |
|
| ||||||||
| MspI | ||||||||
|
| ||||||||
| Schizophrenia (n = 100) | 0 | 0.0 | 46 | 46.0 | 54 | 54.0 | .640 | .424 |
| Lung cancer (n = 100) | 13 | 13.0 | 43 | 43.0 | 44 | 44.0 | 18.620 | <.001 |
| Controls (n = 100) | 0 | 0.0 | 33 | 33.0 | 67 | 67.0 | 11.660 | <.001 |
aDifferences in genotype and allele frequencies; P < .01 from Fisher's exact test.